1101 Mrv1909 01192318302D 17 18 0 0 1 0 999 V2000 5.9375 -0.0353 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 5.1759 -2.9953 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0563 -2.7403 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.6110 -4.4473 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0795 -1.6853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.5085 -1.6853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7940 -0.4479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.5085 0.7896 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.8409 -2.9953 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 4.0960 -3.7799 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 4.5085 -2.5103 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 4.9210 -3.7799 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 5.4058 -4.4473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2229 -1.2728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7940 -1.2728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2229 -0.4479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5085 -0.0353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 16 1 0 0 0 0 2 11 1 0 0 0 0 2 12 1 0 0 0 0 9 3 1 1 0 0 0 10 4 1 1 0 0 0 5 15 2 0 0 0 0 11 6 1 6 0 0 0 6 14 1 0 0 0 0 6 15 1 0 0 0 0 7 15 1 0 0 0 0 7 17 2 0 0 0 0 8 17 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 10 12 1 0 0 0 0 12 13 1 6 0 0 0 14 16 2 0 0 0 0 16 17 1 0 0 0 0 M END > DBMET03580 > drugbank > C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(F)C(N)=NC1=O > InChI=1S/C9H12FN3O4/c1-3-5(14)6(15)8(17-3)13-2-4(10)7(11)12-9(13)16/h2-3,5-6,8,14-15H,1H3,(H2,11,12,16)/t3-,5-,6-,8-/m1/s1 > YSNABXSEHNLERR-ZIYNGMLESA-N > C9H12FN3O4 > 245.21 > 245.081184041 > 6 > 29 > 3.0503816076127635e-06 > 21.77899732441687 > 1 > 3 > 0 > 0 > 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-1,2-dihydropyrimidin-2-one > -1.11 > -1.5511644076666666 > -1.68 > 0 > 0 > 2 > 0 > 14.086021273977448 > 12.587268795179906 > 1.7600220536616382 > 108.37999999999998 > 53.204 > 1 > 1 > 5.16e+00 g/l > 2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-5H,6H,8H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile > 0 > DBMET03580 > 5’-Deoxy-5-fluorocytidine (5'-DFCR) > 8RWB05I6ON $$$$